INTS vs BIIB: Which Stock is Better?
Side-by-side comparison of Intensity Therapeutics Inc and Biogen Inc in 2026
INTS
Intensity Therapeutics Inc
$5.50
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | INTS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $13.87M | $25.88B | BIIB |
| P/E Ratio | N/A | 20.09 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze INTS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INTS or BIIB a better investment?
Comparing INTS and BIIB: Intensity Therapeutics Inc has a market cap of $13.87M while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INTS and BIIB?
INTS (Intensity Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INTS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INTS or BIIB?
INTS has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: INTS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for INTS.
Which is the larger company: INTS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $13.87M for INTS.
Should I buy INTS or BIIB in 2026?
Both INTS and BIIB have investment merit. INTS trades at $5.50 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INTS and BIIB stock?
Key differences: Market Cap ($13.87M vs $25.88B), P/E Ratio (N/A vs 20.1x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).